Skip to main content
. Author manuscript; available in PMC: 2021 Jun 4.
Published in final edited form as: Acc Chem Res. 2020 Oct 19;53(11):2521–2533. doi: 10.1021/acs.accounts.0c00339

Figure 6.

Figure 6.

(A) Schematic summary of in situ spraying of aCD47@CaCO3 nanoparticle-containing fibrin gel in the postsurgery tumor bed. (B) Transmission electron microscopy (TEM) image of aCD47@CaCO3 nanoparticles (scale bar 100 nm). (C) Cryo-SEM images of fibrin gel loaded with aCD47@CaCO3 nanoparticles (scale bar 1 μm). (D) Cumulative release profiles of aCD47 from fibrin at different pH. Data are presented as mean ± SEM. (E) In vivo retention of Cy5.5-labeled aCD47 administered in different formulations after 6 days. (F) Average tumor growth curves in different groups. (G) Schematic illustration of aCD47@CaCO3@fibrin therapy in a mouse model of incomplete tumor resection and distant tumor. (H) Growth curves for left and right tumors in untreated and treated mice. Data are presented as mean ± SEM, *P < 0.05. Reprinted and modified with permission from ref 37. Copyright 2019 Springer Nature Limited.